Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03286595 · ClinicalTrials.gov registry record · NA

Smartphone Applications Youth With Early Psychosis in Community Outpatient Settings

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT03286595 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03286595, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The project aims to test the utility of implementing a mobile health application ("mhealth app") in early psychosis care in the community outpatient setting and in the university medical center setting. We will enroll 60 individuals in the early stages of psychotic illness who are receiving care in two UC Davis affiliated community based early psychosis outpatient programs: the Aldea Child and Family Services SOAR Programs in Napa and Solano Counties (Napa SOAR, and Solano SOAR), as well as the UC Davis Early Psychosis Programs (EDAPT and SacEDAPT clinics). Early psychosis (EP) participants will include individuals at high risk for developing a psychotic illness (termed "clinical high risk" or CHR) and individuals within two years of their first psychotic episode (termed "first episode psychosis" or FEP). Over the course of five months, EP participants will use the app on their mobile device to complete daily surveys assessing mood, social interactions and medication adherence, and weekly surveys assessing clinical symptoms, sleep and medication adherence. EP participants will also complete clinical assessments with UC Davis research staff at the initial and final study appointments (baseline and five month timepoints). Clinicians working in the three early psychosis programs will also participate in the study. In their clinical role, they will interact with EP participants' app data via the Dashboard, a secure web-based portal, and provide feedback on the clinical utility of the data that is provided on the dashboard. EP participants and their clinicians will also provide feedback on the impact of the app on the therapeutic relationship.

Interventions

  • OTHER Mobi mHealth app

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2015-08-19
Est. Completion 2016-12-31
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03286595

The ClinicalTrials.gov registry entry for NCT03286595 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Mobi mHealth app is the first listed.

NCT03286595 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03286595 about?

NCT03286595 is a clinical study titled "Smartphone Applications Youth With Early Psychosis in Community Outpatient Settings". The project aims to test the utility of implementing a mobile health application ("mhealth app") in early psychosis care in the community outpatient setting and in the university medical center setting. We will enroll 60 individuals in the early stages of psychotic illness who are receiving care in ...

What is the current status of trial NCT03286595?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-08-19. Estimated completion is 2016-12-31.

What interventions are being tested in trial NCT03286595?

The interventions under investigation include: Mobi mHealth app (OTHER).

Who is sponsoring clinical trial NCT03286595?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.